Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer.

J Oncol · 2021 · PMC8443385 · PMID 34539781

Europe PMC DOI

hedged sentence

0.1080

closest p · 2.2× alpha

0.1080

boldest claim

The sentences

showed a trendP = 0.108not close (p > 0.1)

When adjusted by tumor size, NLR ≥ 2.49 just showed a trend to decrease CR rate (adjusted OR = 1.547; 95% CI, 0.909–2.631; P = 0.108).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.